nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—ABCB1—Levothyroxine—hypothyroidism	0.0887	0.336	CbGbCtD
Alitretinoin—ABCB1—Liothyronine—hypothyroidism	0.0887	0.336	CbGbCtD
Alitretinoin—ABCB1—Liotrix—hypothyroidism	0.0866	0.328	CbGbCtD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0115	0.0406	CbGpPWpGaD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0105	0.0371	CbGpPWpGaD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0103	0.0364	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.00986	0.0349	CbGpPWpGaD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.00986	0.0349	CbGpPWpGaD
Alitretinoin—Benign intracranial hypertension—Levothyroxine—hypothyroidism	0.00954	0.0347	CcSEcCtD
Alitretinoin—Benign intracranial hypertension—Dextrothyroxine—hypothyroidism	0.00954	0.0347	CcSEcCtD
Alitretinoin—RARG—tongue—hypothyroidism	0.00935	0.0524	CbGeAlD
Alitretinoin—RARG—Nuclear Receptors—THRA—hypothyroidism	0.00846	0.0299	CbGpPWpGaD
Alitretinoin—RXRG—Nuclear Receptors—THRA—hypothyroidism	0.00774	0.0274	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors—THRA—hypothyroidism	0.00759	0.0269	CbGpPWpGaD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00739	0.0261	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptors—THRA—hypothyroidism	0.00728	0.0257	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptors—THRA—hypothyroidism	0.00728	0.0257	CbGpPWpGaD
Alitretinoin—Benign intracranial hypertension—Liotrix—hypothyroidism	0.00702	0.0255	CcSEcCtD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00676	0.0239	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00669	0.0237	CbGpPWpGaD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00663	0.0234	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00635	0.0225	CbGpPWpGaD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00635	0.0225	CbGpPWpGaD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00612	0.0216	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.006	0.0212	CbGpPWpGaD
Alitretinoin—Clotting—Liotrix—hypothyroidism	0.00578	0.021	CcSEcCtD
Alitretinoin—Renal tubular necrosis—Liotrix—hypothyroidism	0.00578	0.021	CcSEcCtD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00575	0.0203	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00575	0.0203	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors—THRB—hypothyroidism	0.00545	0.0193	CbGpPWpGaD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.00514	0.0182	CbGpPWpGaD
Alitretinoin—RXRG—Nuclear Receptors—THRB—hypothyroidism	0.00499	0.0176	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors—THRB—hypothyroidism	0.00489	0.0173	CbGpPWpGaD
Alitretinoin—CYP1A2—urine—hypothyroidism	0.00483	0.0271	CbGeAlD
Alitretinoin—Phlebitis—Liothyronine—hypothyroidism	0.00481	0.0175	CcSEcCtD
Alitretinoin—RARA—Nuclear Receptors—THRB—hypothyroidism	0.00469	0.0166	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptors—THRB—hypothyroidism	0.00469	0.0166	CbGpPWpGaD
Alitretinoin—CRABP1—gonad—hypothyroidism	0.00461	0.0259	CbGeAlD
Alitretinoin—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00457	0.0166	CcSEcCtD
Alitretinoin—CRABP1—pituitary gland—hypothyroidism	0.0045	0.0252	CbGeAlD
Alitretinoin—RARB—heart—hypothyroidism	0.00435	0.0244	CbGeAlD
Alitretinoin—RARG—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00431	0.0152	CbGpPWpGaD
Alitretinoin—RXRG—heart—hypothyroidism	0.00426	0.0239	CbGeAlD
Alitretinoin—CRABP1—The citric acid (TCA) cycle and respiratory electron transport—ATP5O—hypothyroidism	0.00425	0.015	CbGpPWpGaD
Alitretinoin—CRABP2—The citric acid (TCA) cycle and respiratory electron transport—ATP5O—hypothyroidism	0.00425	0.015	CbGpPWpGaD
Alitretinoin—CRABP2—gonad—hypothyroidism	0.00417	0.0234	CbGeAlD
Alitretinoin—CRABP2—pituitary gland—hypothyroidism	0.00407	0.0228	CbGeAlD
Alitretinoin—RXRG—cardiovascular system—hypothyroidism	0.00402	0.0225	CbGeAlD
Alitretinoin—RXRB—heart—hypothyroidism	0.004	0.0224	CbGeAlD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00394	0.0139	CbGpPWpGaD
Alitretinoin—CRABP1—thyroid gland—hypothyroidism	0.00388	0.0217	CbGeAlD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00387	0.0137	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptors—THRA—hypothyroidism	0.00379	0.0134	CbGpPWpGaD
Alitretinoin—Acidosis—Liotrix—hypothyroidism	0.00373	0.0136	CcSEcCtD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00371	0.0131	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00371	0.0131	CbGpPWpGaD
Alitretinoin—CRABP2—adrenal gland—hypothyroidism	0.00363	0.0204	CbGeAlD
Alitretinoin—CRABP2—blood—hypothyroidism	0.00363	0.0204	CbGeAlD
Alitretinoin—RXRG—pituitary gland—hypothyroidism	0.00356	0.0199	CbGeAlD
Alitretinoin—RARG—heart—hypothyroidism	0.00355	0.0199	CbGeAlD
Alitretinoin—CRABP2—thyroid gland—hypothyroidism	0.00351	0.0197	CbGeAlD
Alitretinoin—CRABP2—female gonad—hypothyroidism	0.00339	0.019	CbGeAlD
Alitretinoin—RXRA—female gonad—hypothyroidism	0.00337	0.0189	CbGeAlD
Alitretinoin—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—NKX2-5—hypothyroidism	0.00336	0.0119	CbGpPWpGaD
Alitretinoin—RARA—heart—hypothyroidism	0.00334	0.0187	CbGeAlD
Alitretinoin—CRABP1—testis—hypothyroidism	0.00332	0.0186	CbGeAlD
Alitretinoin—Fluid overload—Liotrix—hypothyroidism	0.00332	0.0121	CcSEcCtD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00331	0.0117	CbGpPWpGaD
Alitretinoin—RARB—adrenal gland—hypothyroidism	0.00325	0.0182	CbGeAlD
Alitretinoin—RXRG—adrenal gland—hypothyroidism	0.00318	0.0178	CbGeAlD
Alitretinoin—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00315	0.0115	CcSEcCtD
Alitretinoin—RARB—thyroid gland—hypothyroidism	0.00314	0.0176	CbGeAlD
Alitretinoin—Myocardial infarction—Liothyronine—hypothyroidism	0.00313	0.0114	CcSEcCtD
Alitretinoin—CRABP1—cerebellum—hypothyroidism	0.00307	0.0172	CbGeAlD
Alitretinoin—RXRG—thyroid gland—hypothyroidism	0.00307	0.0172	CbGeAlD
Alitretinoin—RARB—female gonad—hypothyroidism	0.00303	0.017	CbGeAlD
Alitretinoin—CRABP2—testis—hypothyroidism	0.00301	0.0168	CbGeAlD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.003	0.0106	CbGpPWpGaD
Alitretinoin—RXRB—adrenal gland—hypothyroidism	0.00299	0.0167	CbGeAlD
Alitretinoin—Cyanosis—Liotrix—hypothyroidism	0.00292	0.0106	CcSEcCtD
Alitretinoin—RXRB—thyroid gland—hypothyroidism	0.00288	0.0162	CbGeAlD
Alitretinoin—RARA—gonad—hypothyroidism	0.00286	0.016	CbGeAlD
Alitretinoin—RXRA—liver—hypothyroidism	0.00283	0.0159	CbGeAlD
Alitretinoin—RARA—pituitary gland—hypothyroidism	0.00279	0.0156	CbGeAlD
Alitretinoin—RXRB—female gonad—hypothyroidism	0.00278	0.0156	CbGeAlD
Alitretinoin—CRABP2—cerebellum—hypothyroidism	0.00278	0.0156	CbGeAlD
Alitretinoin—Wheezing—Dextrothyroxine—hypothyroidism	0.00272	0.00991	CcSEcCtD
Alitretinoin—Wheezing—Levothyroxine—hypothyroidism	0.00272	0.00991	CcSEcCtD
Alitretinoin—RARG—adrenal gland—hypothyroidism	0.00265	0.0149	CbGeAlD
Alitretinoin—RARG—blood—hypothyroidism	0.00265	0.0149	CbGeAlD
Alitretinoin—Coagulopathy—Liotrix—hypothyroidism	0.00265	0.00964	CcSEcCtD
Alitretinoin—RXRG—testis—hypothyroidism	0.00263	0.0147	CbGeAlD
Alitretinoin—Tingling sensation—Liotrix—hypothyroidism	0.00257	0.00934	CcSEcCtD
Alitretinoin—Coma—Dextrothyroxine—hypothyroidism	0.00256	0.00932	CcSEcCtD
Alitretinoin—Coma—Levothyroxine—hypothyroidism	0.00256	0.00932	CcSEcCtD
Alitretinoin—Arrhythmia—Liothyronine—hypothyroidism	0.00256	0.00932	CcSEcCtD
Alitretinoin—RARG—thyroid gland—hypothyroidism	0.00256	0.0143	CbGeAlD
Alitretinoin—RARB—liver—hypothyroidism	0.00254	0.0142	CbGeAlD
Alitretinoin—RARA—adrenal gland—hypothyroidism	0.00249	0.014	CbGeAlD
Alitretinoin—RARA—blood—hypothyroidism	0.00249	0.014	CbGeAlD
Alitretinoin—RARB—cerebellum—hypothyroidism	0.00248	0.0139	CbGeAlD
Alitretinoin—RARG—female gonad—hypothyroidism	0.00247	0.0139	CbGeAlD
Alitretinoin—RXRB—testis—hypothyroidism	0.00247	0.0138	CbGeAlD
Alitretinoin—RXRA—Nuclear Receptors—THRB—hypothyroidism	0.00244	0.00865	CbGpPWpGaD
Alitretinoin—RARA—thyroid gland—hypothyroidism	0.00241	0.0135	CbGeAlD
Alitretinoin—Tenderness—Liotrix—hypothyroidism	0.00236	0.0086	CcSEcCtD
Alitretinoin—RXRB—liver—hypothyroidism	0.00234	0.0131	CbGeAlD
Alitretinoin—RARA—female gonad—hypothyroidism	0.00232	0.013	CbGeAlD
Alitretinoin—RXRB—cerebellum—hypothyroidism	0.00228	0.0128	CbGeAlD
Alitretinoin—Cellulitis—Liotrix—hypothyroidism	0.00227	0.00825	CcSEcCtD
Alitretinoin—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00225	0.00817	CcSEcCtD
Alitretinoin—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00225	0.00817	CcSEcCtD
Alitretinoin—RARG—testis—hypothyroidism	0.00219	0.0123	CbGeAlD
Alitretinoin—Ulcer—Liotrix—hypothyroidism	0.00218	0.00794	CcSEcCtD
Alitretinoin—Hypertension—Liothyronine—hypothyroidism	0.00216	0.00784	CcSEcCtD
Alitretinoin—Cardiac failure—Levothyroxine—hypothyroidism	0.00209	0.00759	CcSEcCtD
Alitretinoin—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00209	0.00759	CcSEcCtD
Alitretinoin—RARA—testis—hypothyroidism	0.00206	0.0116	CbGeAlD
Alitretinoin—RARG—cerebellum—hypothyroidism	0.00202	0.0114	CbGeAlD
Alitretinoin—Affect lability—Levothyroxine—hypothyroidism	0.002	0.00729	CcSEcCtD
Alitretinoin—Affect lability—Dextrothyroxine—hypothyroidism	0.002	0.00729	CcSEcCtD
Alitretinoin—Wheezing—Liotrix—hypothyroidism	0.002	0.00729	CcSEcCtD
Alitretinoin—Tachycardia—Liothyronine—hypothyroidism	0.00199	0.00723	CcSEcCtD
Alitretinoin—RARA—liver—hypothyroidism	0.00195	0.0109	CbGeAlD
Alitretinoin—Irritability—Levothyroxine—hypothyroidism	0.00194	0.00707	CcSEcCtD
Alitretinoin—Irritability—Dextrothyroxine—hypothyroidism	0.00194	0.00707	CcSEcCtD
Alitretinoin—Cardiac arrest—Levothyroxine—hypothyroidism	0.00194	0.00704	CcSEcCtD
Alitretinoin—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00194	0.00704	CcSEcCtD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00193	0.00683	CbGpPWpGaD
Alitretinoin—Mood swings—Dextrothyroxine—hypothyroidism	0.00193	0.00702	CcSEcCtD
Alitretinoin—Mood swings—Levothyroxine—hypothyroidism	0.00193	0.00702	CcSEcCtD
Alitretinoin—Hypotension—Liothyronine—hypothyroidism	0.0019	0.00693	CcSEcCtD
Alitretinoin—RARA—cerebellum—hypothyroidism	0.0019	0.0107	CbGeAlD
Alitretinoin—Dehydration—Dextrothyroxine—hypothyroidism	0.00189	0.00689	CcSEcCtD
Alitretinoin—Dehydration—Levothyroxine—hypothyroidism	0.00189	0.00689	CcSEcCtD
Alitretinoin—Coma—Liotrix—hypothyroidism	0.00189	0.00686	CcSEcCtD
Alitretinoin—Lightheadedness—Liotrix—hypothyroidism	0.00185	0.00672	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00179	0.00634	CbGpPWpGaD
Alitretinoin—Sepsis—Liotrix—hypothyroidism	0.00179	0.00651	CcSEcCtD
Alitretinoin—Dysphagia—Dextrothyroxine—hypothyroidism	0.00176	0.0064	CcSEcCtD
Alitretinoin—Dysphagia—Levothyroxine—hypothyroidism	0.00176	0.0064	CcSEcCtD
Alitretinoin—Phlebitis—Liotrix—hypothyroidism	0.00174	0.00632	CcSEcCtD
Alitretinoin—Sweating increased—Dextrothyroxine—hypothyroidism	0.00171	0.00624	CcSEcCtD
Alitretinoin—Sweating increased—Levothyroxine—hypothyroidism	0.00171	0.00624	CcSEcCtD
Alitretinoin—Swelling—Liotrix—hypothyroidism	0.0017	0.00618	CcSEcCtD
Alitretinoin—Cardiac failure congestive—Liotrix—hypothyroidism	0.00165	0.00601	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00164	0.0058	CbGpPWpGaD
Alitretinoin—Renal failure acute—Liotrix—hypothyroidism	0.00162	0.0059	CcSEcCtD
Alitretinoin—Body temperature increased—Liothyronine—hypothyroidism	0.00161	0.00586	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00161	0.00569	CbGpPWpGaD
Alitretinoin—Weight decreased—Levothyroxine—hypothyroidism	0.00159	0.00579	CcSEcCtD
Alitretinoin—Weight decreased—Dextrothyroxine—hypothyroidism	0.00159	0.00579	CcSEcCtD
Alitretinoin—Renal impairment—Liotrix—hypothyroidism	0.00157	0.00572	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00155	0.00563	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00155	0.00563	CcSEcCtD
Alitretinoin—RARA—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00154	0.00545	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00154	0.00545	CbGpPWpGaD
Alitretinoin—Myocardial infarction—Levothyroxine—hypothyroidism	0.00154	0.0056	CcSEcCtD
Alitretinoin—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00154	0.0056	CcSEcCtD
Alitretinoin—Cardiac failure—Liotrix—hypothyroidism	0.00153	0.00558	CcSEcCtD
Alitretinoin—Cerebrovascular accident—Liotrix—hypothyroidism	0.00153	0.00556	CcSEcCtD
Alitretinoin—Sweating—Levothyroxine—hypothyroidism	0.0015	0.00547	CcSEcCtD
Alitretinoin—Sweating—Dextrothyroxine—hypothyroidism	0.0015	0.00547	CcSEcCtD
Alitretinoin—Affect lability—Liotrix—hypothyroidism	0.00147	0.00536	CcSEcCtD
Alitretinoin—Irritability—Liotrix—hypothyroidism	0.00143	0.0052	CcSEcCtD
Alitretinoin—Cardiac arrest—Liotrix—hypothyroidism	0.00142	0.00518	CcSEcCtD
Alitretinoin—Mood swings—Liotrix—hypothyroidism	0.00142	0.00516	CcSEcCtD
Alitretinoin—Blood creatinine increased—Liotrix—hypothyroidism	0.0014	0.0051	CcSEcCtD
Alitretinoin—Dehydration—Liotrix—hypothyroidism	0.00139	0.00507	CcSEcCtD
Alitretinoin—Flushing—Levothyroxine—hypothyroidism	0.00131	0.00476	CcSEcCtD
Alitretinoin—Flushing—Dextrothyroxine—hypothyroidism	0.00131	0.00476	CcSEcCtD
Alitretinoin—Abdominal distension—Liotrix—hypothyroidism	0.0013	0.00474	CcSEcCtD
Alitretinoin—Dysphagia—Liotrix—hypothyroidism	0.00129	0.00471	CcSEcCtD
Alitretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—ATP5O—hypothyroidism	0.00129	0.00455	CbGpPWpGaD
Alitretinoin—Bronchospasm—Liotrix—hypothyroidism	0.00127	0.00463	CcSEcCtD
Alitretinoin—Sweating increased—Liotrix—hypothyroidism	0.00126	0.00459	CcSEcCtD
Alitretinoin—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00126	0.00458	CcSEcCtD
Alitretinoin—Arrhythmia—Levothyroxine—hypothyroidism	0.00126	0.00458	CcSEcCtD
Alitretinoin—Alopecia—Dextrothyroxine—hypothyroidism	0.00124	0.00453	CcSEcCtD
Alitretinoin—Alopecia—Levothyroxine—hypothyroidism	0.00124	0.00453	CcSEcCtD
Alitretinoin—Tension—Dextrothyroxine—hypothyroidism	0.0012	0.00438	CcSEcCtD
Alitretinoin—Tension—Levothyroxine—hypothyroidism	0.0012	0.00438	CcSEcCtD
Alitretinoin—Nervousness—Dextrothyroxine—hypothyroidism	0.00119	0.00433	CcSEcCtD
Alitretinoin—Nervousness—Levothyroxine—hypothyroidism	0.00119	0.00433	CcSEcCtD
Alitretinoin—Weight decreased—Liotrix—hypothyroidism	0.00117	0.00426	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—THRA—hypothyroidism	0.00116	0.00409	CbGpPWpGaD
Alitretinoin—Tremor—Dextrothyroxine—hypothyroidism	0.00115	0.00418	CcSEcCtD
Alitretinoin—Tremor—Levothyroxine—hypothyroidism	0.00115	0.00418	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Liotrix—hypothyroidism	0.00114	0.00414	CcSEcCtD
Alitretinoin—Renal failure—Liotrix—hypothyroidism	0.00113	0.00413	CcSEcCtD
Alitretinoin—Myocardial infarction—Liotrix—hypothyroidism	0.00113	0.00412	CcSEcCtD
Alitretinoin—Agitation—Levothyroxine—hypothyroidism	0.00113	0.0041	CcSEcCtD
Alitretinoin—Agitation—Dextrothyroxine—hypothyroidism	0.00113	0.0041	CcSEcCtD
Alitretinoin—Sweating—Liotrix—hypothyroidism	0.00111	0.00403	CcSEcCtD
Alitretinoin—Palpitations—Dextrothyroxine—hypothyroidism	0.00108	0.00394	CcSEcCtD
Alitretinoin—Palpitations—Levothyroxine—hypothyroidism	0.00108	0.00394	CcSEcCtD
Alitretinoin—Convulsion—Levothyroxine—hypothyroidism	0.00106	0.00386	CcSEcCtD
Alitretinoin—Convulsion—Dextrothyroxine—hypothyroidism	0.00106	0.00386	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—THRA—hypothyroidism	0.00106	0.00374	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—SLC5A7—hypothyroidism	0.00105	0.00373	CbGpPWpGaD
Alitretinoin—Arthralgia—Dextrothyroxine—hypothyroidism	0.00104	0.0038	CcSEcCtD
Alitretinoin—Arthralgia—Levothyroxine—hypothyroidism	0.00104	0.0038	CcSEcCtD
Alitretinoin—Anxiety—Levothyroxine—hypothyroidism	0.00104	0.00378	CcSEcCtD
Alitretinoin—Anxiety—Dextrothyroxine—hypothyroidism	0.00104	0.00378	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—THRA—hypothyroidism	0.00104	0.00367	CbGpPWpGaD
Alitretinoin—Hypoaesthesia—Liotrix—hypothyroidism	0.00103	0.00375	CcSEcCtD
Alitretinoin—Confusional state—Dextrothyroxine—hypothyroidism	0.00101	0.00367	CcSEcCtD
Alitretinoin—Confusional state—Levothyroxine—hypothyroidism	0.00101	0.00367	CcSEcCtD
Alitretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypothyroidism	0.000994	0.00352	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—THRA—hypothyroidism	0.000993	0.00351	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—THRA—hypothyroidism	0.000993	0.00351	CbGpPWpGaD
Alitretinoin—Shock—Dextrothyroxine—hypothyroidism	0.000985	0.00358	CcSEcCtD
Alitretinoin—Shock—Levothyroxine—hypothyroidism	0.000985	0.00358	CcSEcCtD
Alitretinoin—Tachycardia—Levothyroxine—hypothyroidism	0.000977	0.00355	CcSEcCtD
Alitretinoin—Tachycardia—Dextrothyroxine—hypothyroidism	0.000977	0.00355	CcSEcCtD
Alitretinoin—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000967	0.00352	CcSEcCtD
Alitretinoin—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000967	0.00352	CcSEcCtD
Alitretinoin—RXRA—Endogenous sterols—POMC—hypothyroidism	0.000966	0.00342	CbGpPWpGaD
Alitretinoin—Flushing—Liotrix—hypothyroidism	0.000962	0.0035	CcSEcCtD
Alitretinoin—Arrhythmia—Liotrix—hypothyroidism	0.000926	0.00337	CcSEcCtD
Alitretinoin—CYP1A2—blood—hypothyroidism	0.000924	0.00518	CbGeAlD
Alitretinoin—Alopecia—Liotrix—hypothyroidism	0.000916	0.00333	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000912	0.00332	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000912	0.00332	CcSEcCtD
Alitretinoin—Insomnia—Levothyroxine—hypothyroidism	0.000905	0.00329	CcSEcCtD
Alitretinoin—Insomnia—Dextrothyroxine—hypothyroidism	0.000905	0.00329	CcSEcCtD
Alitretinoin—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000892	0.00325	CcSEcCtD
Alitretinoin—Dyspnoea—Levothyroxine—hypothyroidism	0.000892	0.00325	CcSEcCtD
Alitretinoin—CYP1A2—thyroid gland—hypothyroidism	0.000892	0.005	CbGeAlD
Alitretinoin—Flatulence—Liotrix—hypothyroidism	0.000889	0.00323	CcSEcCtD
Alitretinoin—Tension—Liotrix—hypothyroidism	0.000885	0.00322	CcSEcCtD
Alitretinoin—Nervousness—Liotrix—hypothyroidism	0.000876	0.00319	CcSEcCtD
Alitretinoin—RARG—Gene Expression—ZNF764—hypothyroidism	0.000863	0.00305	CbGpPWpGaD
Alitretinoin—Fatigue—Dextrothyroxine—hypothyroidism	0.000863	0.00314	CcSEcCtD
Alitretinoin—Fatigue—Levothyroxine—hypothyroidism	0.000863	0.00314	CcSEcCtD
Alitretinoin—Vision blurred—Liotrix—hypothyroidism	0.00085	0.00309	CcSEcCtD
Alitretinoin—Tremor—Liotrix—hypothyroidism	0.000845	0.00307	CcSEcCtD
Alitretinoin—Agitation—Liotrix—hypothyroidism	0.000829	0.00302	CcSEcCtD
Alitretinoin—Feeling abnormal—Levothyroxine—hypothyroidism	0.000825	0.003	CcSEcCtD
Alitretinoin—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000825	0.003	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000823	0.00291	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000818	0.00298	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000818	0.00298	CcSEcCtD
Alitretinoin—Syncope—Liotrix—hypothyroidism	0.000809	0.00294	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000803	0.00284	CbGpPWpGaD
Alitretinoin—Palpitations—Liotrix—hypothyroidism	0.000797	0.0029	CcSEcCtD
Alitretinoin—Urticaria—Dextrothyroxine—hypothyroidism	0.000795	0.00289	CcSEcCtD
Alitretinoin—Urticaria—Levothyroxine—hypothyroidism	0.000795	0.00289	CcSEcCtD
Alitretinoin—Loss of consciousness—Liotrix—hypothyroidism	0.000793	0.00288	CcSEcCtD
Alitretinoin—Abdominal pain—Levothyroxine—hypothyroidism	0.000791	0.00288	CcSEcCtD
Alitretinoin—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000791	0.00288	CcSEcCtD
Alitretinoin—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000791	0.00288	CcSEcCtD
Alitretinoin—Body temperature increased—Levothyroxine—hypothyroidism	0.000791	0.00288	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—ZNF764—hypothyroidism	0.000789	0.00279	CbGpPWpGaD
Alitretinoin—Convulsion—Liotrix—hypothyroidism	0.000781	0.00284	CcSEcCtD
Alitretinoin—Hypertension—Liotrix—hypothyroidism	0.000779	0.00283	CcSEcCtD
Alitretinoin—RARB—Gene Expression—ZNF764—hypothyroidism	0.000774	0.00274	CbGpPWpGaD
Alitretinoin—Chest pain—Liotrix—hypothyroidism	0.000768	0.00279	CcSEcCtD
Alitretinoin—Arthralgia—Liotrix—hypothyroidism	0.000768	0.00279	CcSEcCtD
Alitretinoin—Anxiety—Liotrix—hypothyroidism	0.000765	0.00278	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—IYD—hypothyroidism	0.000753	0.00266	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—IYD—hypothyroidism	0.000753	0.00266	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000753	0.00266	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—THRB—hypothyroidism	0.000744	0.00263	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—ZNF764—hypothyroidism	0.000742	0.00263	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—ZNF764—hypothyroidism	0.000742	0.00263	CbGpPWpGaD
Alitretinoin—Confusional state—Liotrix—hypothyroidism	0.000742	0.0027	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000738	0.00261	CbGpPWpGaD
Alitretinoin—Oedema—Liotrix—hypothyroidism	0.000736	0.00268	CcSEcCtD
Alitretinoin—Anaphylactic shock—Liotrix—hypothyroidism	0.000736	0.00268	CcSEcCtD
Alitretinoin—Infection—Liotrix—hypothyroidism	0.000731	0.00266	CcSEcCtD
Alitretinoin—Shock—Liotrix—hypothyroidism	0.000724	0.00263	CcSEcCtD
Alitretinoin—RXRA—Circadian Clock—AVP—hypothyroidism	0.000724	0.00256	CbGpPWpGaD
Alitretinoin—CYP1A2—liver—hypothyroidism	0.000723	0.00405	CbGeAlD
Alitretinoin—Tachycardia—Liotrix—hypothyroidism	0.000718	0.00261	CcSEcCtD
Alitretinoin—Asthenia—Levothyroxine—hypothyroidism	0.000718	0.00261	CcSEcCtD
Alitretinoin—Asthenia—Dextrothyroxine—hypothyroidism	0.000718	0.00261	CcSEcCtD
Alitretinoin—Hyperhidrosis—Liotrix—hypothyroidism	0.000712	0.00259	CcSEcCtD
Alitretinoin—Pruritus—Levothyroxine—hypothyroidism	0.000708	0.00258	CcSEcCtD
Alitretinoin—Pruritus—Dextrothyroxine—hypothyroidism	0.000708	0.00258	CcSEcCtD
Alitretinoin—RARA—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000708	0.0025	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000708	0.0025	CbGpPWpGaD
Alitretinoin—Anorexia—Liotrix—hypothyroidism	0.000702	0.00255	CcSEcCtD
Alitretinoin—Hypotension—Liotrix—hypothyroidism	0.000688	0.0025	CcSEcCtD
Alitretinoin—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000685	0.00249	CcSEcCtD
Alitretinoin—Diarrhoea—Levothyroxine—hypothyroidism	0.000685	0.00249	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—THRB—hypothyroidism	0.000681	0.00241	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000671	0.00244	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—THRB—hypothyroidism	0.000668	0.00236	CbGpPWpGaD
Alitretinoin—Insomnia—Liotrix—hypothyroidism	0.000666	0.00242	CcSEcCtD
Alitretinoin—Paraesthesia—Liotrix—hypothyroidism	0.000661	0.0024	CcSEcCtD
Alitretinoin—Dyspnoea—Liotrix—hypothyroidism	0.000656	0.00239	CcSEcCtD
Alitretinoin—ABCB1—adrenal cortex—hypothyroidism	0.000656	0.00368	CbGeAlD
Alitretinoin—CRABP1—Metabolism—ATP5O—hypothyroidism	0.00064	0.00226	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ATP5O—hypothyroidism	0.00064	0.00226	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—THRB—hypothyroidism	0.00064	0.00226	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—THRB—hypothyroidism	0.00064	0.00226	CbGpPWpGaD
Alitretinoin—Decreased appetite—Liotrix—hypothyroidism	0.00064	0.00233	CcSEcCtD
Alitretinoin—Vomiting—Dextrothyroxine—hypothyroidism	0.000636	0.00231	CcSEcCtD
Alitretinoin—Vomiting—Levothyroxine—hypothyroidism	0.000636	0.00231	CcSEcCtD
Alitretinoin—Fatigue—Liotrix—hypothyroidism	0.000635	0.00231	CcSEcCtD
Alitretinoin—ABCB1—heart—hypothyroidism	0.000634	0.00356	CbGeAlD
Alitretinoin—Rash—Dextrothyroxine—hypothyroidism	0.000631	0.0023	CcSEcCtD
Alitretinoin—Rash—Levothyroxine—hypothyroidism	0.000631	0.0023	CcSEcCtD
Alitretinoin—Dermatitis—Levothyroxine—hypothyroidism	0.00063	0.00229	CcSEcCtD
Alitretinoin—Dermatitis—Dextrothyroxine—hypothyroidism	0.00063	0.00229	CcSEcCtD
Alitretinoin—Constipation—Liotrix—hypothyroidism	0.00063	0.00229	CcSEcCtD
Alitretinoin—Headache—Levothyroxine—hypothyroidism	0.000627	0.00228	CcSEcCtD
Alitretinoin—Headache—Dextrothyroxine—hypothyroidism	0.000627	0.00228	CcSEcCtD
Alitretinoin—Feeling abnormal—Liotrix—hypothyroidism	0.000607	0.00221	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—TPO—hypothyroidism	0.000602	0.00213	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—TPO—hypothyroidism	0.000602	0.00213	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Liotrix—hypothyroidism	0.000602	0.00219	CcSEcCtD
Alitretinoin—ABCB1—cardiovascular system—hypothyroidism	0.000599	0.00336	CbGeAlD
Alitretinoin—Nausea—Dextrothyroxine—hypothyroidism	0.000594	0.00216	CcSEcCtD
Alitretinoin—Nausea—Levothyroxine—hypothyroidism	0.000594	0.00216	CcSEcCtD
Alitretinoin—Urticaria—Liotrix—hypothyroidism	0.000585	0.00213	CcSEcCtD
Alitretinoin—Body temperature increased—Liotrix—hypothyroidism	0.000582	0.00212	CcSEcCtD
Alitretinoin—Abdominal pain—Liotrix—hypothyroidism	0.000582	0.00212	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000558	0.00197	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000558	0.00197	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—THRA—hypothyroidism	0.000556	0.00197	CbGpPWpGaD
Alitretinoin—ABCB1—gonad—hypothyroidism	0.000543	0.00305	CbGeAlD
Alitretinoin—Hypersensitivity—Liotrix—hypothyroidism	0.000542	0.00197	CcSEcCtD
Alitretinoin—ABCB1—pituitary gland—hypothyroidism	0.00053	0.00297	CbGeAlD
Alitretinoin—Asthenia—Liotrix—hypothyroidism	0.000528	0.00192	CcSEcCtD
Alitretinoin—Pruritus—Liotrix—hypothyroidism	0.000521	0.00189	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—THRA—hypothyroidism	0.000518	0.00183	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—THRA—hypothyroidism	0.000509	0.0018	CbGpPWpGaD
Alitretinoin—Diarrhoea—Liotrix—hypothyroidism	0.000504	0.00183	CcSEcCtD
Alitretinoin—RARB—Gene Expression—THRA—hypothyroidism	0.000499	0.00176	CbGpPWpGaD
Alitretinoin—Dizziness—Liotrix—hypothyroidism	0.000487	0.00177	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—THRA—hypothyroidism	0.000478	0.00169	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—THRA—hypothyroidism	0.000478	0.00169	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—IGF1—hypothyroidism	0.000475	0.00168	CbGpPWpGaD
Alitretinoin—ABCB1—adrenal gland—hypothyroidism	0.000473	0.00265	CbGeAlD
Alitretinoin—ABCB1—blood—hypothyroidism	0.000473	0.00265	CbGeAlD
Alitretinoin—Vomiting—Liotrix—hypothyroidism	0.000468	0.0017	CcSEcCtD
Alitretinoin—Rash—Liotrix—hypothyroidism	0.000464	0.00169	CcSEcCtD
Alitretinoin—Dermatitis—Liotrix—hypothyroidism	0.000464	0.00169	CcSEcCtD
Alitretinoin—Headache—Liotrix—hypothyroidism	0.000461	0.00168	CcSEcCtD
Alitretinoin—ABCB1—thyroid gland—hypothyroidism	0.000457	0.00256	CbGeAlD
Alitretinoin—RXRA—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000449	0.00159	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IGF1—hypothyroidism	0.000446	0.00158	CbGpPWpGaD
Alitretinoin—ABCB1—female gonad—hypothyroidism	0.000442	0.00248	CbGeAlD
Alitretinoin—Nausea—Liotrix—hypothyroidism	0.000437	0.00159	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—SLC5A5—hypothyroidism	0.000421	0.00149	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NKX2-5—hypothyroidism	0.000396	0.0014	CbGpPWpGaD
Alitretinoin—ABCB1—testis—hypothyroidism	0.000392	0.0022	CbGeAlD
Alitretinoin—RXRA—Gene Expression—ZNF764—hypothyroidism	0.000387	0.00137	CbGpPWpGaD
Alitretinoin—ABCB1—liver—hypothyroidism	0.00037	0.00208	CbGeAlD
Alitretinoin—RXRA—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000369	0.0013	CbGpPWpGaD
Alitretinoin—RXRA—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000364	0.00129	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NKX2-5—hypothyroidism	0.000362	0.00128	CbGpPWpGaD
Alitretinoin—ABCB1—cerebellum—hypothyroidism	0.000362	0.00203	CbGeAlD
Alitretinoin—RARG—Gene Expression—THRB—hypothyroidism	0.000358	0.00127	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NKX2-5—hypothyroidism	0.000355	0.00126	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000342	0.00121	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NKX2-5—hypothyroidism	0.000341	0.00121	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NKX2-5—hypothyroidism	0.000341	0.00121	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000337	0.00119	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—THRB—hypothyroidism	0.000334	0.00118	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000328	0.00116	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—THRB—hypothyroidism	0.000328	0.00116	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—THRB—hypothyroidism	0.000321	0.00114	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—THRB—hypothyroidism	0.000308	0.00109	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—THRB—hypothyroidism	0.000308	0.00109	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00028	0.000989	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—TSHB—hypothyroidism	0.000279	0.000986	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—TSHB—hypothyroidism	0.000279	0.000986	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CLTC—hypothyroidism	0.000275	0.000974	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—THRA—hypothyroidism	0.000249	0.000882	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3C2A—hypothyroidism	0.000248	0.000879	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3C2A—hypothyroidism	0.000248	0.000879	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000245	0.000867	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000245	0.000867	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IGF1—hypothyroidism	0.000233	0.000823	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—IYD—hypothyroidism	0.000228	0.000806	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—SLC5A5—hypothyroidism	0.000209	0.000738	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—SLC5A5—hypothyroidism	0.000209	0.000738	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ATP5O—hypothyroidism	0.000194	0.000686	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—POMC—hypothyroidism	0.000193	0.000684	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TPO—hypothyroidism	0.000182	0.000645	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NKX2-5—hypothyroidism	0.000178	0.000628	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000171	0.000605	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000169	0.000597	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—THRB—hypothyroidism	0.000161	0.000568	CbGpPWpGaD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000143	0.000506	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000135	0.000477	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000135	0.000477	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VAV3—hypothyroidism	0.00013	0.000459	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000116	0.000411	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000112	0.000395	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—POMC—hypothyroidism	0.000109	0.000386	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—POMC—hypothyroidism	0.000109	0.000386	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000106	0.000376	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—IYD—hypothyroidism	9.11e-05	0.000322	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TSHB—hypothyroidism	8.44e-05	0.000298	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ATP5O—hypothyroidism	7.75e-05	0.000274	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3C2A—hypothyroidism	7.52e-05	0.000266	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.42e-05	0.000262	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TPO—hypothyroidism	7.28e-05	0.000258	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—IYD—hypothyroidism	7.27e-05	0.000257	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	6.83e-05	0.000242	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC5A5—hypothyroidism	6.32e-05	0.000223	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ATP5O—hypothyroidism	6.18e-05	0.000219	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—POMC—hypothyroidism	6.16e-05	0.000218	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TPO—hypothyroidism	5.81e-05	0.000206	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.39e-05	0.000191	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.39e-05	0.000191	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.24e-05	0.00015	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TSHB—hypothyroidism	3.37e-05	0.000119	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—POMC—hypothyroidism	3.3e-05	0.000117	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3C2A—hypothyroidism	3.01e-05	0.000106	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TSHB—hypothyroidism	2.69e-05	9.52e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.52e-05	8.93e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	2.4e-05	8.49e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.37e-05	8.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC5A5—hypothyroidism	2.01e-05	7.13e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—POMC—hypothyroidism	1.32e-05	4.67e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—POMC—hypothyroidism	1.05e-05	3.73e-05	CbGpPWpGaD
